Published in Protein Sci on February 01, 1999
Single-molecule height measurements on microsomal cytochrome P450 in nanometer-scale phospholipid bilayer disks. Proc Natl Acad Sci U S A (2002) 1.98
Domain motion in cytochrome P450 reductase: conformational equilibria revealed by NMR and small-angle x-ray scattering. J Biol Chem (2009) 1.87
Differences in a conformational equilibrium distinguish catalysis by the endothelial and neuronal nitric-oxide synthase flavoproteins. J Biol Chem (2008) 1.25
Human cytochrome P450 oxidoreductase deficiency caused by the Y181D mutation: molecular consequences and rescue of defect. Drug Metab Dispos (2009) 1.02
NADPH-cytochrome P450 oxidoreductase: prototypic member of the diflavin reductase family. Arch Biochem Biophys (2012) 1.00
Association of cytochrome P450 enzymes is a determining factor in their catalytic activity. J Comput Aided Mol Des (2005) 0.98
Redox-linked domain movements in the catalytic cycle of cytochrome p450 reductase. Structure (2013) 0.92
Functional characterisation of an engineered multidomain human P450 2E1 by molecular Lego. J Biol Inorg Chem (2005) 0.85
Tricyclic [1,2,4]triazine 1,4-dioxides as hypoxia selective cytotoxins. J Med Chem (2008) 0.83
Impeded electron transfer from a pathogenic FMN domain mutant of methionine synthase reductase and its responsiveness to flavin supplementation. Biochemistry (2008) 0.83
Molecular view of an electron transfer process essential for iron-sulfur protein biogenesis. Proc Natl Acad Sci U S A (2013) 0.83
Inhibition of NADPH cytochrome P450 reductase by the model sulfur mustard vesicant 2-chloroethyl ethyl sulfide is associated with increased production of reactive oxygen species. Toxicol Appl Pharmacol (2010) 0.82
Kinetic and structural characterization of the interaction between the FMN binding domain of cytochrome P450 reductase and cytochrome c. J Biol Chem (2014) 0.82
Dynamic control of electron transfers in diflavin reductases. Int J Mol Sci (2012) 0.82
Cytochrome P450 17A1 Interactions with the FMN Domain of Its Reductase as Characterized by NMR. J Biol Chem (2015) 0.80
Pseudosymmetry, high copy number and twinning complicate the structure determination of Desulfovibrio desulfuricans (ATCC 29577) flavodoxin. Acta Crystallogr D Biol Crystallogr (2009) 0.80
Molecular dynamics simulations give insight into the conformational change, complex formation, and electron transfer pathway for cytochrome P450 reductase. Protein Sci (2013) 0.80
Crystal structure of cindoxin, the P450cin redox partner. Biochemistry (2014) 0.79
Flavodoxin cofactor binding induces structural changes that are required for protein-protein interactions with NADP(+) oxidoreductase and pyruvate formate-lyase activating enzyme. Biochim Biophys Acta (2013) 0.78
Fusion of Ferredoxin and Cytochrome P450 Enables Direct Light-Driven Biosynthesis. ACS Chem Biol (2016) 0.76
Functional characterization of the re-face loop spanning residues 536-541 and its interactions with the cofactor in the flavin mononucleotide-binding domain of flavocytochrome P450 from Bacillus megaterium. Biochemistry (2009) 0.76
The dual function of flavodiiron proteins: oxygen and/or nitric oxide reductases. J Biol Inorg Chem (2016) 0.75
The catalytic function of cytochrome P450 is entwined with its membrane-bound nature. F1000Res (2017) 0.75
Altered CYP19A1 and CYP3A4 Activities Due to Mutations A115V, T142A, Q153R and P284L in the Human P450 Oxidoreductase. Front Pharmacol (2017) 0.75
Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A (1991) 119.63
Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci U S A (1985) 68.48
Hepatic triphosphopyridine nucleotide-cytochrome c reductase: isolation, characterization, and kinetic studies. J Biol Chem (1962) 4.15
Electron transfer by domain movement in cytochrome bc1. Nature (1998) 4.08
Microsomal triphosphopyridine nucleotide-cytochrome c reductase of liver. J Biol Chem (1962) 3.62
Three-dimensional structure of NADPH-cytochrome P450 reductase: prototype for FMN- and FAD-containing enzymes. Proc Natl Acad Sci U S A (1997) 3.15
Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450's. Science (1993) 3.00
Atomic structure of ferredoxin-NADP+ reductase: prototype for a structurally novel flavoenzyme family. Science (1991) 2.68
Identification of the binding site on cytochrome P450 2B4 for cytochrome b5 and cytochrome P450 reductase. J Biol Chem (1998) 2.13
Immunochemical evidence for an association of heme oxygenase with the microsomal electron transport system. J Biol Chem (1972) 1.91
Resolution of the cytochrome P-450-containing omega-hydroxylation system of liver microsomes into three components. J Biol Chem (1969) 1.84
NADPH-cytochrome P-450 oxidoreductase: flavin mononucleotide and flavin adenine dinucleotide domains evolved from different flavoproteins. Biochemistry (1986) 1.83
Cytochrome b5 reduction by NADPH-cytochrome P-450 reductase. J Biol Chem (1979) 1.52
Dissection of NADPH-cytochrome P450 oxidoreductase into distinct functional domains. Proc Natl Acad Sci U S A (1994) 1.51
Control of oxidation-reduction potentials in flavodoxin from Clostridium beijerinckii: the role of conformation changes. Biochemistry (1997) 1.45
Comparison of the crystal structures of a flavodoxin in its three oxidation states at cryogenic temperatures. J Mol Biol (1991) 1.44
Structure of oxidized flavodoxin from Anacystis nidulans. J Mol Biol (1983) 1.40
Some properties of hepatic reduced nicotinamide adenine dinucleotide phosphate-cytochrome c reductase. Biochemistry (1973) 1.40
Role of acidic residues in the interaction of NADPH-cytochrome P450 oxidoreductase with cytochrome P450 and cytochrome c. J Biol Chem (1995) 1.38
Structure of the oxidized long-chain flavodoxin from Anabaena 7120 at 2 A resolution. Protein Sci (1992) 1.19
An unusual yet strongly conserved flavoprotein reductase in bacteria and mammals. Trends Biochem Sci (1991) 1.13
Evidence for a new physiological role of hepatic NADPH:ferricytochrome (P-450) oxidoreductase. Direct electron input to the microsomal fatty acid chain elongation system. J Biol Chem (1981) 1.13
Localization of cytochrome c-binding domain on NADPH-cytochrome P-450 reductase. J Biol Chem (1986) 1.12
Probing the role of lysines and arginines in the catalytic function of cytochrome P450d by site-directed mutagenesis. Interaction with NADPH-cytochrome P450 reductase. J Biol Chem (1991) 1.11
A model for human cytochrome P450 2D6 based on homology modeling and NMR studies of substrate binding. Biochemistry (1996) 1.08
A close family resemblance: the importance of structure in understanding cytochromes P450. Structure (1998) 1.04
Role of electrostatic interactions in the reaction of NADPH-cytochrome P-450 reductase with cytochromes P-450. Arch Biochem Biophys (1988) 1.00
Tertiary structure of oxidized flavodoxin from an eukaryotic red alga Chondrus crispus at 2.35-A resolution. Localization of charged residues and implication for interaction with electron transfer partners. J Biol Chem (1990) 0.94
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as a substrate of cytochrome P450 2D6: allosteric effects of NADPH-cytochrome P450 reductase. Biochemistry (1997) 0.93
Differences in the mechanism of functional interaction between NADPH-cytochrome P-450 reductase and its redox partners. Mol Pharmacol (1986) 0.90
Negatively charged anabaena flavodoxin residues (Asp144 and Glu145) are important for reconstitution of cytochrome P450 17alpha-hydroxylase activity. J Biol Chem (1997) 0.87
Crystallization and preliminary X-ray diffraction studies of human cytochrome P450 reductase. J Struct Biol (1996) 0.80
Studies in the biochemistry of micro-organisms: The metabolic products of the Penicillium brevi-compactum series. Biochem J (1932) 11.42
Confidential inquiry into quality of care before admission to intensive care. BMJ (1998) 11.32
Experimental annotation of the human genome using microarray technology. Nature (2001) 10.39
Studies in the biochemistry of micro-organisms: The metabolic products of Penicillium Charlesii G. Smith. Biochem J (1934) 10.22
Studies in the biochemistry of micro-organisms: The metabolic products of Aspergillus terreus Thom. A new mould metabolic product-terrein. Biochem J (1935) 7.74
Studies in the biochemistry of micro-organisms: The metabolic products of Aspergillus terreus Thom. Part II. Two new chlorine-containing mould metabolic products, geodin and erdin. Biochem J (1936) 6.60
Hours, volume, and type of work of preregistration house officers. BMJ (1990) 5.68
A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. Military Medical Consortium for Applied Retroviral Research. N Engl J Med (1991) 4.23
Regulation of JNK signaling by GSTp. EMBO J (1999) 4.06
Studies in the biochemistry of micro-organisms: The metabolic products of Byssochlamys fulva Olliver and Smith. Biochem J (1933) 3.74
Activating K-Ras mutations outwith 'hotspot' codons in sporadic colorectal tumours - implications for personalised cancer medicine. Br J Cancer (2010) 3.25
Cardiovascular and catecholamine responses to laryngoscopy with and without tracheal intubation. Br J Anaesth (1987) 3.05
Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am J Psychiatry (1998) 3.02
Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes. J Exp Med (1987) 3.02
Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J Exp Med (1988) 2.85
Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacology (1998) 2.70
Postoperative wound infection: a computer analysis. Br J Surg (1971) 2.67
PrP genotype and agent effects in scrapie: change in allelic interaction with different isolates of agent in sheep, a natural host of scrapie. J Gen Virol (1994) 2.63
Sources and types of referral to a haematology department. Health Trends (1992) 2.48
Symptoms after primary immunisation with DTP and with DT vaccine. Lancet (1984) 2.48
The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. AJNR Am J Neuroradiol (1993) 2.44
Purchasing 'legal highs' on the Internet--is there consistency in what you get? QJM (2010) 2.43
The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxyanisole and ethoxyquin. Biochem Soc Trans (2000) 2.40
Effects of adrenaline on human blood platelets. J Physiol (1967) 2.38
Selection of an obstetric data base for a microcomputer and its use for on-line production of birth notification forms, discharge summaries and perinatal audit. Br J Obstet Gynaecol (1983) 2.36
Does cerebral blood flow decline in healthy aging? A PET study with partial-volume correction. J Nucl Med (2000) 2.33
Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases. Proc Natl Acad Sci U S A (1998) 2.32
Role of an inhibitory pyrimidine element and polypyrimidine tract binding protein in repression of a regulated alpha-tropomyosin exon. RNA (1998) 2.18
Echocardiographic measurement of the normal adult right ventricle. Br Heart J (1986) 2.16
Studies in the biochemistry of micro-organisms: Fumaryl-dl-alanine (fumaromono-dl-alanide), a metabolic product of Penicillium resticulosum sp.nov. Biochem J (1942) 2.13
Should we patch corneal abrasions? A meta-analysis. J Fam Pract (1998) 2.12
Epidural anaesthesia and analgesia: better outcome after major surgery?. Growing evidence suggests so. BMJ (1999) 2.10
Reversible restoration of the birefringence of cold-treated, isolated mitotic apparatus of surf clam eggs with chick brain tubulin. Nature (1974) 2.08
Science, medicine, and the future: Pharmacogenetics. BMJ (2000) 2.06
Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis (1997) 2.05
The mechanism of N-terminal acetylation of proteins. CRC Crit Rev Biochem (1985) 2.02
Early marker for Alzheimer's disease: the atrophic hippocampus. Lancet (1989) 2.02
A complex between the MHC class I homologue encoded by human cytomegalovirus and beta 2 microglobulin. Nature (1990) 2.01
Antibiotics and surgery for vesicoureteric reflux: a meta-analysis of randomised controlled trials. Arch Dis Child (2003) 1.99
The release of nucleotides, 5-hydroxytryptamine and enzymes from human blood platelets during aggregation. J Physiol (1968) 1.97
Identification of the primary gene defect at the cytochrome P450 CYP2D locus. Nature (1990) 1.96
Alzheimer disease: measuring loss of cerebral gray matter with MR imaging. Radiology (1991) 1.92
Accuracy of burn size estimation and subsequent fluid resuscitation prior to arrival at the Yorkshire Regional Burns Unit. A three year retrospective study. Burns (1999) 1.92
Smooth muscle-specific switching of alpha-tropomyosin mutually exclusive exon selection by specific inhibition of the strong default exon. EMBO J (1994) 1.91
Nomenclature for human CYP2D6 alleles. Pharmacogenetics (1996) 1.91
Individual risk factors for hip osteoarthritis: obesity, hip injury, and physical activity. Am J Epidemiol (1998) 1.90
Nuclear magnetic resonance spectroscopy of amino acids, peptides, and proteins. Adv Protein Chem (1970) 1.89
Oesophageal apoplexy. Lancet (1974) 1.88
Ward design in relation to postoperative wound infection. I. Br Med J (1971) 1.85
Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis (1993) 1.84
National symptom surveillance using calls to a telephone health advice service--United Kingdom, December 2001-February 2003. MMWR Morb Mortal Wkly Rep (2004) 1.82
Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis (1997) 1.78
Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Biochem Pharmacol (1994) 1.76
Crystal structure of the DNA modifying enzyme beta-glucosyltransferase in the presence and absence of the substrate uridine diphosphoglucose. EMBO J (1994) 1.76
The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma. Gut (2005) 1.73
Use of capillary blood in measurement of arterial PO2. Br Med J (1968) 1.73
Neurofilaments are transported rapidly but intermittently in axons: implications for slow axonal transport. J Neurosci (2000) 1.73
Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease. Diabetes (2001) 1.70
Genetic analysis of the human cytochrome P450 CYP2C9 locus. Pharmacogenetics (1996) 1.67
Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Am J Cardiol (2001) 1.66
Changing epidemiology and ecology of highly pathogenic avian H5N1 influenza viruses. Avian Dis (2007) 1.65
ABC of intensive care. Criteria for admission. BMJ (1999) 1.65
CT diagnostic features of Alzheimer disease: importance of the choroidal/hippocampal fissure complex. AJNR Am J Neuroradiol (1990) 1.62
Repeatability and validity of an upper limb and neck discomfort questionnaire: the utility of the standardized Nordic questionnaire. Occup Med (Lond) (1999) 1.62
Raised mortality from lung cancer and high sex ratios of births associated with industrial pollution. Br J Ind Med (1985) 1.62
CYT387, a selective JAK1/JAK2 inhibitor: in vitro assessment of kinase selectivity and preclinical studies using cell lines and primary cells from polycythemia vera patients. Leukemia (2009) 1.61
Physicians' knowledge of cost: the case of diagnostic tests. Inquiry (1976) 1.60
Molecular mechanisms of drug resistance. Biochem J (1990) 1.56
Genetics of cognition: outline of a collaborative twin study. Twin Res (2001) 1.56
Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways. J Pharmacol Exp Ther (2001) 1.56
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Memory function in normal aging. Neurology (1992) 1.55
Investigation of interaction between N-acetyltransferase 2 and heterocyclic amines as potential risk factors for colorectal cancer. Carcinogenesis (2003) 1.54
Haemodynamic and myocardial effects of hyperbaric oxygen in dogs subjected to haemorrhage. Cardiovasc Res (1971) 1.54
Weight loss in obese people has structure-modifying effects on medial but not on lateral knee articular cartilage. Ann Rheum Dis (2012) 1.54
Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis (1991) 1.53
Gastroesophageal reflux and aspiration of gastric contents in anesthetic practice. Anesth Analg (2001) 1.53
The influence of age on the response of major depression to electroconvulsive therapy: a C.O.R.E. Report. Am J Geriatr Psychiatry (2001) 1.53
Treatment of Clostridium welchii infection with hyperbaric oxygen. Surg Gynecol Obstet (1968) 1.53
Munchausen's syndrome manifesting as factitious hypoglycaemia. Diabetologia (2001) 1.52
Fractures of the femoral shaft in children. Incidence, mechanisms, and sociodemographic risk factors. J Bone Joint Surg Am (1999) 1.52
The mechanism of action of ribonuclease. Proc Natl Acad Sci U S A (1969) 1.51
Dissection of NADPH-cytochrome P450 oxidoreductase into distinct functional domains. Proc Natl Acad Sci U S A (1994) 1.51
From Phisohex to Hibiscrub. Br Med J (1973) 1.51
CYP2D6 genotyping and the association with lung cancer susceptibility. Pharmacogenetics (1994) 1.50
Provision of platelet support for fetuses and neonates affected by severe fetomaternal alloimmune thrombocytopenia. Br J Haematol (2001) 1.49
Alternative splicing in the human cytochrome P450IIB6 gene generates a high level of aberrant messages. Nucleic Acids Res (1989) 1.48
Bulimia nervosa. The impact of pregnancy on mother and baby. Br J Psychiatry (1987) 1.48
Movements of the vocal cords on induction of anaesthesia with thiopentone or propofol. Br J Anaesth (1992) 1.47
Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient. Int J Cancer (1987) 1.47
Incidence of latex sensitization among latex glove users. J Allergy Clin Immunol (1998) 1.46
Increased contractility and calcium sensitivity in cardiac myocytes isolated from endurance trained rats. Cardiovasc Res (2001) 1.46
The toxicity of oxygen. Anesthesiology (1972) 1.45
Is scrapie solely a genetic disease? Nature (1997) 1.45
Intravitreal penetration of teicoplanin. Eye (Lond) (1998) 1.45
Binding of flexible ligands to macromolecules. Nature (1975) 1.45